Investigação de fatores de risco cardiovascular modificáveis em pacientes portadores de transtorno afetivo bipolar
Investigation of modifiable cardiovascular risk factors in patients with bipolar affective disorder
DOI:
https://doi.org/10.34119/bjhrv5n6-226Keywords:
Transtorno Bipolar, fatores de risco de doenças cardíacas, serviços comunitários de saúde mentalAbstract
Introdução: As doenças cardiovasculares representam a principal causa de morte entre os pacientes com transtorno afetivo bipolar, os quais apresentam uma elevada prevalência de fatores de risco cardiovascular tradicionais, como diabetes, dislipidemia, hipertensão, tabagismo e obesidade, em comparação com a população geral. Objetivo: O presente estudo tem por objetivo identificar as taxas de investigação de fatores de risco cardiovascular modificáveis numa amostra de pacientes portadores de transtorno afetivo bipolar atendidos na rede de saúde pública de Curitiba. Método: A amostra constitui-se de quarenta pacientes que foram admitidos na Unidade de Estabilização Psiquiátrica entre setembro de 2020 e fevereiro de 2021, com o diagnóstico de transtorno afetivo bipolar. Trata-se de um estudo transversal retrospectivo, através de revisão de prontuário. Resultado: Os dois fatores de risco cardiovascular menos investigados na população estudada foram inatividade física e obesidade, avaliados em 5% e 27,5% da amostra estudada, respectivamente. Dislipidemia foi investigada em 42,5% dos pacientes, diabetes mellitus em 62,5% e tabagismo em 70% dos pacientes. Doença renal crônica e hipertensão arterial sistêmica foram os fatores mais investigados, em 92,5% e 72,5% dos casos, respectivamente. Conclusão: Este estudo conclui que alguns fatores de risco cardiovascular são pouco investigados em indivíduos com transtorno afetivo bipolar, destacando-se a inatividade física, a obesidade e a dislipidemia, demonstrando que integrar a abordagem de condições psiquiátricas com a de condições médicas gerais é ainda um desafio na prática clínica.
References
NHLBI. Assessing cardiovascular risk: Systematic Evidence Review From the Risk Assessment Work Group, 2013. 2013: 1-139. Disponível em: https://www.nhlbi.nih.gov/health-topics/assessing-cardiovascular-risk.
Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: A review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:1-9.
WHO. Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. [Internet]. [citado 19 de julho de 2021]. Disponível em: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death.
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.
Brown JC, Gerhardt TE, Kwon E Risk Factors For Coronary Artery Disease. StatPearls. 2020;36(1):40.
Bensenor IM, Goulart AC, Santos I de S, Lotufo PA. Prevalência De Fatores De Risco Cardiovascular No Mundo E No Brasil. Rev Soc Cardiol Estado São Paulo. 2019;29(1):18–24.
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2015 update : A report from the American Heart Association. Circulation. 2015;131:29–39 p.
Gomes FA. Transtorno bipolar e comorbidades clínicas. Debates Em Psiquiatr Internet. 2016;6(5):20–3.
Goldstein BI, Carnethon MR, Matthews KA, Mcintyre RS, Miller GE, Raghuveer G, et al. Major Depressive Disorder and Bipolar Disorder and Early Cardiovascular Disease. 2015;965–86.
Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and Mortality in Bipolar Disorder A Swedish National Cohort Study. 2013;1–9.
B. Oliveira K; L VR; Almeida. Mortalidade prematura por doença cardiovascular no transtorno bipolar: fatores de risco e implicações no tratamento. 2016;44–54
Kupfer DJ. The Increasing Medical Burden in Bipolar Disorder. 2015;15213(1).
Wageck AR, Torres FS, Gama CS, Martins DS, Scotton E. Cardiovascular risk and bipolar disorder : factors associated with a positive coronary calcium score in patients with bipolar disorder type 1. 2018;163–8.
Costa AMN. Bipolar disorder: Burden of disease and related costs. Arch Clin Psychiatry São Paulo. 2008;35(3):104–10.
Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. The Lancet. 2016;387(10027):1561–72.
Curitiba. Linha guia da saúde mental. Secretaria Municipal de Saúde de Curitiba; 2018: 1-108.
FEAS. Casa Irmã Dulce [Internet]. 2022. Disponível em: http://www.feaes.curitiba.pr.gov.br/uep-casa-irma-dulce.html
Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study. BMJ Online. 2017;357.
Gomes FA, Almeida KM, Magalha PV, Caetano SC. Cardiovascular risk factors in outpatients with bipolar disorder : a report from the Brazilian Research Network in Bipolar Disorder. 2013;126–30.
Janney CA, Fagiolini A, Swartz Holly A, Jakicic JM, Holleman RG, Richardson CR. Are adults with bipolar disorder active? Objectively measured physical activity and sedentary behavior using accelerometry. J Affect Disord. 2014;0:498–504.
WHO. WHO Guidelines on physical activity and sedentary behaviour, Web Annex, Evidence Profiles [Internet]. World Health Organization. 2020: 1-531. Disponível em: https://apps.who.int/iris/handle/10665/336657.
Vancampfort D, Firth J, Schuch FB, Rosenbaum S, Mugisha J, Hallgren M, Probst M, Ward PB, Gaughran F, De Hert M, Carvalho AF SB. Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis. World Psychiatry. 2017;16(3):308–15.
Melo MCA, Daher EDF, Albuquerque SGC, Bruin VMSD. Exercise in bipolar patients: A systematic review. J Affect Disord. 2016;198:32–8.
Abosi, O; Lopes, S; Schmitz SFG. Cardiometabolic Effects of Psychotropic MedicationsNo Title. Horm Mol Biol Clin Investig Author Manuscr. 2019;36(1):1–27.
Bai YM, Li CT, Tsai SJ, Tu PC, Chen MH, Su TP. Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder. BMC Psychiatry. 2016;16(1):1–9.
Kahl KG. Direct and indirect effects of psychopharmacological treatment on the cardiovascular system. Horm Mol Biol Clin Investig. 2018;36(1):1–16.
McElroy SL, Keck PE. Obesity in bipolar disorder: An overview. Curr Psychiatry Rep. 2012;14(6):650–8.
Reilly-Harrington NA, Feig EH, Huffman JC. Bipolar Disorder and Obesity: Contributing Factors, Impact on Clinical Course, and the Role of Bariatric Surgery. Curr Obes Rep. 2018;7(4):294–300.
Calkin C, Van De Velde C, Růžičková M, Slaney C, Garnham J, Hajek T, et al. Can body mass index help predict outcome in patients with bipolar disorder? Bipolar Disord. 2009;11(6):650–6.
Grover, Sandeep, Chakrabarti S, Kulhara P, Malhotra N. Metabolic syndrome in bipolar disorders. Indian J Psychol Med. 2012;34(2):110–8.
Kocakaya H, Batmaz S, Demir O, Songur E, Celikbas Z. Metabolic syndrome in bipolar disorder: Prevalence, demographics and clinical correlates in individuals with bipolar I, bipolar II, and healthy controls. Rev Psiquiatr Clin. 2018;45(6):143–9.
McIntyre RS, Danilewitz M, Liauw SS, Kemp DE, Nguyen HTT, Kahn LS, et al. Bipolar disorder and metabolic syndrome: An international perspective. J Affect Disord. 2010;126(3):366–87.
Smith DJ, Martin D, McLean G, Langan J, Guthrie B, Mercer SW. Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: A cross sectional study. BMC Med. 2013;11(1):1–11.
Ayerbe L, Forgnone I, Addo J, Siguero A, Gelati S, Ayis S. Hypertension risk and clinical care in patients with bipolar disorder or schizophrenia; a systematic review and meta-analysis. J Affect Disord. 2018;225:665–70.
Heffner, JL; Strawn, JR; DelBello, MP; Strakowski, SM; Anthenelli RM. The Co-occurrence of Cigarette Smoking and Bipolar Disorder: Phenomenology and Treatment Considerations. Bipolar Disord. 2011;13(0):439–53.
Slyepchenko A, Brunoni AR, McIntyre RS, Quevedo J, Carvalho AF. The Adverse Effects of Smoking on Health Outcomes in Bipolar Disorder: A Review and Synthesis of Biological Mechanisms. Curr Mol Med. 2016;16(2):187–205.
WHO. Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care. 2014: 1-17. Disponível em: https://apps.who.int/iris/bitstream/handle/10665/112835/9789241506953_eng.pdf.
